HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyclin-Dependent Kinase Inhibitor p19

An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.
Also Known As:
CDKN2D Protein; Cyclin-Dependent Kinase Inhibitor 2D; INK4D Protein; p19INK4D Protein; Cyclin Dependent Kinase Inhibitor 2D; Cyclin Dependent Kinase Inhibitor p19
Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cao, Yanan: 1 article (07/2015)
2. Cheng, Yulong: 1 article (07/2015)
3. Gu, Weiqiong: 1 article (07/2015)
4. Jiang, Xiuli: 1 article (07/2015)
5. Ning, Guang: 1 article (07/2015)
6. Shan, Aijing: 1 article (07/2015)
7. Su, Yutong: 1 article (07/2015)
8. Wang, Weiqing: 1 article (07/2015)
9. Bartek, J: 1 article (08/2000)
10. Bartkova, J: 1 article (08/2000)

Related Diseases

1. Hematologic Neoplasms (Hematological Malignancy)
2. Thymoma (Thymic Carcinoma)
3. Testicular Neoplasms (Testicular Cancer)
4. Neoplasms (Cancer)
5. Carcinoma in Situ

Related Drugs and Biologics

1. Phosphoric Monoester Hydrolases (Phosphatases)
2. Tensins